Academic Dermatology Associates

Albuquerque, New Mexico 87106-5239

0 studies enrolling now · 66 studies all time

What they study most

ACTINIC KERATOSIS, Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Alopecia, Arthritis, Psoriatic, Atopic Dermatitis, Basal Cell Carcinoma, Cutaneous Common Warts, Distal, Subungual Onychomycosis, Erythematous (Type One) Rosacea, Herpes Labialis

Studies at this site

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp — Completed
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris — Completed
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma — Completed
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis — Completed
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts — Completed
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis — Completed
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis — Completed
Dose Range Study of CD5789 in Acne Vulgaris — Completed
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis — Completed
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp — Completed
Phase 3 Papulopustular Rosacea Study — Completed
CP-690-550 Ointment For Chronic Plaque Psoriasis — Completed
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis — Stopped early
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail — Completed
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel — Completed
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis — Completed
A Study of a New Drug Treatment for Acne — Completed
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne — Completed
A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis — Completed
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) — Completed
Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis — Completed
Study of Different Doses of a Novel Treatment for Onychomycosis — Completed
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. — Completed
Safety Study of Cosmetic Tissue Augmentation in People of Color — Completed
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children — Completed
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis — Completed
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) — Completed
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 — Completed
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies — Completed
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses — Completed
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris — Completed
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies — Completed
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations — Completed
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris — Completed
Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis — Completed
An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea — Status unconfirmed
An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis — Completed
Clinical Trial in Females With Female Pattern Hair Loss — Completed
Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) — Withdrawn before enrolling
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis — Stopped early